TrimTabs-國際自由現金流優質主動型ETF TTAI 深 滬
交易中 06-24 11:41:06 美东时间
29.99
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 29.99
- 總市值 5998.00万
- 52周最高 30.3535
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 26.591
- 委 比 0.00%
- 總股本 200.00万
- 歷史最高 32.324
- 量 比 0
- 振 幅 0.00%
- 歷史最低 10.621
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股收盘：以色列暂停袭击伊朗！三大指数涨跌不一，芯片股集体反弹，英特尔大涨超11%
以色列暂停袭击伊朗！三大指数涨跌不一，道指跌0.16%，纳指涨0.86%；芯片股集体反弹，英特尔大涨超11%；存储、光通信集体走强，美光涨超9%市值重回万亿美元，应用光电涨超11%>>
06-09 07:05
美股机会日报 | 反弹来了？纳指期货升1.4%；黄仁勋、马斯克齐唱多：回调创造买入机会！美光盘前涨近7%
反弹来了？纳指期货盘前升1.4%；黄仁勋、马斯克齐唱多：回调创造买入机会！美光盘前涨近7%，英伟达涨超2%；今夜凌晨1:00！苹果WWDC迎来AI正名之战>>
06-08 20:09
Biggest stock movers Monday: NRIX, HON, and more
Stock futures edged lower Monday morning while crude oil prices marched higher as Wall Street faced a dual threat from escalating geopolitical conflict and mounting tech skepticism. Here are some of M...
06-08 18:09
Reported Sunday, Lilly's Foundayo Delivers Up To 30.4 Lbs Weight Loss In Perimenopausal Women Across ATTAIN-1 And ATTAIN-2 Clinical Trials
In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4lbs (14.4%) and those in post-menopause lost upto28.2lbs(14.1%)In ATTAIN-2, women taking Foundayo lost significant weight across all stages of menopause,
06-08 15:22
开辟减肥药“新蓝海”！礼来(LLY.US)公布最新临床数据，Foundayo有望填补更年期肥胖治疗空白
礼来公司(LLY.US)表示，针对后期临床试验数据的最新分析显示，其实验性减肥疗法Foundayo能使超重或肥胖女性实现显著减重。
06-08 09:45
Lilly’s ATTAIN-MAINTAIN Trial: A Fresh Pill-Based Play in the Obesity Market
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical stud...
06-05 00:30
Eli Lilly Announces Foundayo Shown To Significantly Reduce Body Weight In Phase 3 ATTAIN-1, ATTAIN-2 Studies
https://investor.lilly.com/news-releases/news-release-details/foundayo-orforglipron-once-daily-pill-taken-without-food-or
05-22 20:55
Eli Lilly Announces Detailed Results From Two Late-Phase Trials Showing That People With Obesity Maintained Their Weight Loss Long Term With Either Foundayo Or Lower-Dose Zepbound After Switching From Higher Doses Of Injectable Incretin Therapy
Eli Lilly and Company (NYSE:LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after
05-13 06:06
Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today
GSAT, XOM, CYCN, LLY, INTC were among the stocks seen trending on Wednesday, April 1, 2026.
04-02 10:33
What's Going On With Structure Therapeutics Stock On Wednesday?
Structure Therapeutics shares rose, likely driven by FDA approval of a competing obesity treatment, boosting sentiment.
04-02 02:07
